Anthem Biosciences IPO: A Deep Dive into the Promises and Controversies
The biotechnology sector in India has been witnessing a surge in investor interest, driven by innovation, increasing healthcare demands, and global partnerships. Among the latest entrants eyeing the public markets is Anthem Biosciences, a Bengaluru-based biopharmaceutical company specializing in contract research and manufacturing services (CRAMS). The company’s upcoming initial public offering (IPO) has generated significant…
